• Channels
    • All News
    • In Focus
    • Special
    • AI
    • Bioregnum
    • Biotech Voices
    • Cell/Gene Tx
    • China
    • Coronavirus
    • Deals
    • Diagnostics
    • Discovery
    • FDA+
    • Financing
    • Health Tech
    • Law
    • Letters to the Editor
    • Manufacturing
    • Marketing
    • Nikkei Biotechnology
    • Opinion
    • Outsourcing
    • Peer Review
    • People
    • Pharma
    • R&D
    • Startups
    • Weekly
  • Webinars
  • Biopharma Jobs
  • More
    • Work at Endpoints
    • Letter to Editors
    • Editorial Standards
    • IPO Tracker
    • Webinars
    • Events
    • Sponsored Posts
    • Advertise
    • Privacy Policy
    • Endpoints Merch
    • About Us
    • Help
  • SIGN UP
  • LOG IN

Tome plans lay­offs amid strug­gle; FDA turns away Re­gen­eron; Next-gen obe­si­ty start­up launch­es; James Sabry joins ...

8 months ago
Weekly

Gene edit­ing start­up Tome Bio­sciences to lay off al­most all work­ers

8 months ago
People

Re­searchers down­play study that found a link be­tween semaglu­tide and men­tal health

8 months ago
R&D

J&J grants 'short ex­ten­sion' for cer­ti­fi­ca­tion of talc set­tle­ment vote

8 months ago
Pharma
Law

CDER chief says 's­tan­dards have not changed,' ex­plain­ing in­crease in CRLs for bi­o­log­ics

8 months ago
FDA+
Manufacturing

Novo's in­no­va­tion hub ex­pands to Bay Area; SIGA's new Tpoxx or­der

8 months ago
News Briefing

Jazz talk­ing with Japan reg­u­la­tors about an­ti-seizure med Epid­i­olex af­ter tri­al set­back

8 months ago
R&D

Gen­mab makes two C-suite ad­di­tions as COO leaves; James Sabry leads a re­vamped sup­port­ing cast at Bio­Marin

8 months ago
Peer Review

Gene in­ser­tion start­up Tome Bio­sciences stops lab work as CEO shifts fo­cus to deal talks

8 months ago
Startups
Cell/Gene Tx

On­col­o­gy biotech Bicara un­veils IPO pitch same day as Zenas

8 months ago
Financing
Startups

FDA to host ad­comm on PD-L1 as a pre­dic­tive bio­mark­er for check­point in­hibitors

8 months ago
FDA+

Au­toim­mune biotech Zenas files for IPO amid sum­mer lull for pub­lic de­buts

8 months ago
Financing
Startups

FDA ap­proves re­for­mu­lat­ed Covid boost­ers for fall sea­son

8 months ago
Pharma
FDA+

FDA clos­es the door on Intar­ci­a's eight-year bid for di­a­betes drug-de­vice com­bo

8 months ago
FDA+

Liq­uidia sues FDA over ex­clu­siv­i­ty de­ci­sion to de­lay Yutrepi­a's full ap­proval

8 months ago
FDA+
Law

Il­lu­mi­na Ven­tures sets out for $300M third fund

8 months ago
Financing
Startups

Q&A: GSK CSO Tony Wood on stay­ing out of obe­si­ty, 'care­ful' can­cer am­bi­tions, and AI's fu­ture in R&D

8 months ago
People
R&D

Fu­ji­film Diosynth opens new UK fa­cil­i­ty; Bo­ra com­pletes Emer­gent fac­to­ry buy

8 months ago
Manufacturing

How Wal­greens plans to re­vive re­tail phar­ma­cy with­in three years

8 months ago
Health Tech

Dig­i­tal health start­up Sesame starts of­fer­ing com­pound­ed weight loss shots

8 months ago
Startups
Health Tech

Ver­sant and No­var­tis build 'Chi­nook 2.0' for RNA ther­a­pies in kid­ney dis­eases

8 months ago
Financing
Startups

Bio­gen, Ei­sai’s Leqem­bi wins UK ap­proval, but not im­me­di­ate NHS cov­er­age

8 months ago
Pharma

Up­dat­ed: Chi­nese gov­ern­ment in­dicts Japan­ese Astel­las em­ploy­ee for es­pi­onage

8 months ago
People
China

FDA warns hos­pi­tals against us­ing Pfiz­er's re­main­ing potas­si­um in­jec­tions for chil­dren

8 months ago
Pharma
FDA+
First page Previous page 105106107108109110111 Next page Last page
Endpoints News

Bioscience & Technology Business Center
The University of Kansas
Lawrence, Kansas

Latest

  • All News
  • Special
  • In Focus

Channels

  • AI
  • Bioregnum
  • Biotech Voices
  • Cell/Gene Tx
  • China
  • Coronavirus
  • Deals
  • Diagnostics
  • Discovery
  • FDA+
  • Financing
  • Health Tech
  • Law
  • Letters to the Editor
  • Manufacturing
  • Marketing
  • Nikkei Biotechnology
  • Opinion
  • Outsourcing
  • Peer Review
  • People
  • Pharma
  • R&D
  • Startups
  • Weekly

More

  • Work at Endpoints
  • Letter to Editors
  • Editorial Standards
  • IPO Tracker
  • Events
  • Webinars
  • Sponsored Posts
  • Advertise
  • Endpoints Merch
  • About Us
  • Help

Work in biotech

  • Endpoints Careers

© Endpoints News 2025

  • Help
  • Advertise
  • Privacy Policy
  • Business Model
FT Specialist Logo
A service from the Financial Times